# Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease

> **NCT06319339** · EARLY_PHASE1 · RECRUITING · sponsor: **University of Nebraska** · enrollment: 20 (estimated)

## Conditions studied

- Peripheral Artery Disease
- Peripheral Vascular Diseases
- Peripheral Arterial Disease
- Peripheral Arterial Occlusive Disease

## Interventions

- **DRUG:** Vumerity
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT06319339
- **Lead sponsor:** University of Nebraska
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-14
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06319339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06319339, "Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06319339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*